Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study
Open Access
- 27 December 2025
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 234, 116201
Abstract
No abstract availableKeywords
Funding Information
- Stockholms Läns Landsting
- Cancerfonden (FoUI-1023897)
- Cancerfonden (24 3826 Pj)
- Cancerfonden (FoUI-975235)
- Cancerfonden (20 0156\u2009F)
- Radiumhemmets Forskningsfonder
This publication has 28 references indexed in Scilit:
- Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma – A Swedish retrospective real-world study (NEO-MEL)European Journal of Cancer, 2025
- Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028ESMO Open, 2025
- Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022JAMA Network Open, 2022
- Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trialThe Lancet, 2022
- Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trialThe Lancet Oncology, 2020
- Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma ConsortiumThe Lancet Oncology, 2019
- Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trialThe Lancet Oncology, 2019
- The Swedish cause of death registerEuropean Journal of Epidemiology, 2017
- Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma RegisterEuropean Journal of Cancer, 2016
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trialThe Lancet, 2012